Clinical trial Recruiting at 1 site Early Phase 1 Interventional Ages 40 to 65

Improving brain function in adults with Type 2 diabetes using thiamine

Official title: Type 2 Diabetes Mellitus and Blood Brain Barrier Improvement - A Randomized Clinical Trial

Run by University of California, Los Angeles · NCT06322212 · Data updated 2026-11-12

This study is testing if taking thiamine can help improve brain function and mood in adults with Type 2 diabetes.

Quick facts

PhaseEarly Phase 1
Study typeInterventional
Ages40 Years to 65 Years
SexAll
Enrollment52 (estimated)
SponsorUniversity of California, Los Angeles
Academic / other
Locations1 site (Los Angeles, California)
StatusRecruiting
StartedAugust 1, 2024
Main results expectedDecember 31, 2026
Study endsMarch 31, 2027
Registry record updatedMarch 13, 2026
Trial IDNCT06322212 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults diagnosed with Type 2 diabetes who are outpatient and can comfortably undergo MRI imaging.

Probably not a fit

Patients with a history of stroke, current thiamine intake, or certain neurological and psychiatric disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of thiamine (vitamin B1) treatment on brain function in adults diagnosed with Type 2 diabetes mellitus (T2DM). Participants will undergo brain MRI scans, cognitive assessments, blood tests, and questionnaires to evaluate the potential benefits of thiamine supplementation. The study aims to determine if thiamine can improve blood-brain barrier function and subsequently enhance cognitive and mood functions in T2DM patients. Participants will visit UCLA twice over a six-month period for assessments lasting approximately 2.5 to 3 hours each.

Why it matters

Potential benefit: If successful, this treatment could improve cognitive function and mood in patients with Type 2 diabetes, potentially reducing the risk of dementia.

How similar studies have gone: Pre-clinical studies have suggested that thiamine treatment may improve blood-brain barrier function, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosed T2DM
* Outpatient status
* Able to lay flat for imaging

Exclusion Criteria:

* A previous history of stroke
* Current in-take of thiamine
* Known thiamine allergy
* Seizure disorder
* Head trauma
* Myocardial infarction
* Current pregnancy (if female)
* Diagnosed neuropsychiatric disorders (clinical depression, schizophrenia, manic-depression)
* Diagnosed dementia
* Sleep disordered breathing
* Airway or chest deformities that would interfere with breathing
* Chronic obstructive pulmonary disease
* Cystic fibrosis
* Presence of brain mass lesions
* Any history of drug abuse (e.g., cocaine, tobacco, or cannabis)
* Renal failure (requiring dialysis)
* All T2DM adults with metallic and electronic implants (phrenic or cardiac pacemakers; although some pacemakers and cardioverter defibrillators are safe at a low magnetic field, they are not safe at 3.0-Tesla scanner)
* Non-removable insulin pump/glucose sensor
* Braces
* Body weight more than 300 pounds (weight and height will be used to calculate BMI to determine if the patient will fit in the scanner and stay within parameters of size restrictions of MRI scanner table)
* Any other contraindications to MRI, such as claustrophobia, or metallic-based tattoos, as per MRI safety website suggestions, will also be excluded.

Where it's running

  • UCLA
    Los Angeles, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.